Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018160690) RNA PHARMACEUTICAL FORMULATIONS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF ZIKA VIRUS INFECTION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/160690 International Application No.: PCT/US2018/020220
Publication Date: 07.09.2018 International Filing Date: 28.02.2018
IPC:
A61K 39/12 (2006.01) ,A61K 9/127 (2006.01) ,A61K 31/713 (2006.01) ,A61K 31/7088 (2006.01) ,C12N 15/113 (2010.01) ,C12N 15/11 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
12
Viral antigens
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
127
Liposomes
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7088
Compounds having three or more nucleosides or nucleotides
713
Double-stranded nucleic acids or oligonucleotides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7088
Compounds having three or more nucleosides or nucleotides
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09
Recombinant DNA-technology
11
DNA or RNA fragments; Modified forms thereof
113
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09
Recombinant DNA-technology
11
DNA or RNA fragments; Modified forms thereof
Applicants:
CAI, Yibin [CN/US]; US (US)
TANG, Shenggao [CN/CN]; US (US)
LU, Patrick Yang [US/US]; US (US)
GUAN, Jian [CN/US]; US (US)
LU, Alan, Yang [US/US]; US (US)
GUANGZHOU NANOTIDES PHARMACEUTICALS CO., LTD. [CN/CN]; Guangzhou International Bio-Island 12 Luoxuan 3 Road Suite 306 Guangzhou, CN (AllExceptUS)
Inventors:
CAI, Yibin; US
TANG, Shenggao; US
LU, Patrick Yang; US
GUAN, Jian; US
LU, Alan, Yang; US
Agent:
KARNY, Geoffrey M.; US
Priority Data:
62/465,09628.02.2017US
Title (EN) RNA PHARMACEUTICAL FORMULATIONS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF ZIKA VIRUS INFECTION
(FR) FORMULATIONS PHARMACEUTIQUES D'ARN POUR LE TRAITEMENT PROPHYLACTIQUE ET THÉRAPEUTIQUE D'UNE INFECTION PAR LE VIRUS ZIKA
Abstract:
(EN) The present invention provides prophylactic and therapeutic pharmaceutical compositions comprising either siRNA or mRNA molecules for prevention and treatment of Zika virus infection and provides methods for their use.
(FR) La présente invention concerne des compositions pharmaceutiques prophylactiques et thérapeutiques comprenant soit des molécules d'ARNsi, soit des molécules d'ARNm, destinées à la prévention et au traitement d'une infection par le virus Zika, ainsi que des méthodes pour leur utilisation.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)